Chm-1 appears to maintain cartilage homeostasis by inhibiting hypoxia-inducible factor-2α (HIF-2α) induced catabolic activity, and may be a potential therapeutic target for the inhibition of cartilage degradation resulting from osteoarthritis [25]. The gene discussed is CNMD; the disease is osteoarthritis.